Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polyzois Makras

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Haematologica|April 2, 2011
Skeletal implications of isolated bone marrow mastocytosisPolyzois Makras
Nature Clinical Practice. Endocrinology & Metabolism|August 21, 2008
Selection of antiresorptive or anabolic treatments for postmenopausal osteoporosisSocrates Papapoulos, Polyzois Makras
Endocrine|January 2, 2015
Langerhans cell histiocytosis and pituitary functionPolyzois Makras, Gregory Kaltsas
Neuroendocrinology|September 11, 2010
Skeletal diseases in Cushing's syndrome: osteoporosis versus arthropathyGregory Kaltsas, Polyzois Makras
Archives of Osteoporosis|October 17, 2020
Fracture risk among treatment-naïve postmenopausal women with osteopenia in Greece: results from the "ACROSS" studyAthanasios D Anastasilakis, Polyzois Makras
Hormones (Athens, Greece)|July 3, 2009
Medical treatment of hypercalcaemiaPolyzois Makras, Socrates E Papapoulos
Metabolism: Clinical and Experimental|October 21, 2017
Bone disease in primary hyperparathyroidismPolyzois Makras, Athanasios D Anastasilakis
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Bisphosphonates in the Management of Patients with Postmenopausal Osteoporosis; Back to the FutureSocrates E Papapoulos, Polyzois Makras
Expert Opinion on Drug Safety|December 29, 2020
Questions and facts regarding denosumab discontinuation among postmenopausal womenPolyzois Makras, Athanasios D Anastasilakis
Expert Review of Endocrinology & Metabolism|October 7, 2018
Systemic and endocrine manifestations of Langerhans' cell histiocytosis: current concepts in diagnosis and managementPolyzois Makras, Georgios Piaditis, Gregory A Kaltsas
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Haematologica|April 2, 2011
Skeletal implications of isolated bone marrow mastocytosisPolyzois Makras
Nature Clinical Practice. Endocrinology & Metabolism|August 21, 2008
Selection of antiresorptive or anabolic treatments for postmenopausal osteoporosisSocrates Papapoulos, Polyzois Makras
Endocrine|January 2, 2015
Langerhans cell histiocytosis and pituitary functionPolyzois Makras, Gregory Kaltsas
Neuroendocrinology|September 11, 2010
Skeletal diseases in Cushing's syndrome: osteoporosis versus arthropathyGregory Kaltsas, Polyzois Makras
Archives of Osteoporosis|October 17, 2020
Fracture risk among treatment-naïve postmenopausal women with osteopenia in Greece: results from the "ACROSS" studyAthanasios D Anastasilakis, Polyzois Makras
Hormones (Athens, Greece)|July 3, 2009
Medical treatment of hypercalcaemiaPolyzois Makras, Socrates E Papapoulos
Metabolism: Clinical and Experimental|October 21, 2017
Bone disease in primary hyperparathyroidismPolyzois Makras, Athanasios D Anastasilakis
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Bisphosphonates in the Management of Patients with Postmenopausal Osteoporosis; Back to the FutureSocrates E Papapoulos, Polyzois Makras
Expert Opinion on Drug Safety|December 29, 2020
Questions and facts regarding denosumab discontinuation among postmenopausal womenPolyzois Makras, Athanasios D Anastasilakis
Expert Review of Endocrinology & Metabolism|October 7, 2018
Systemic and endocrine manifestations of Langerhans' cell histiocytosis: current concepts in diagnosis and managementPolyzois Makras, Georgios Piaditis, Gregory A Kaltsas
Pageof 14